Approxima Secures €7.3M Series A Co-led by Panakès and ENEA Tech

Deal News | Mar 05, 2025 | Legal Community Italy

Approxima Secures €7.3M Series A Co-led by Panakès and ENEA Tech

Rucellai & Raffaelli provided legal assistance to Panakès Partners and ENEA Tech and Biomedical in their co-led Series A investment in Approxima Srl, a MedTech startup. Approxima aims to develop a revolutionary percutaneous technology for the right ventricular remodeling to address tricuspid insufficiency. The €7.3 million round will facilitate advanced preclinical and pilot clinical studies, bringing Approxima's innovative solution closer to definitive clinical validation. This partnership reflects a commitment to advancing technology in the life sciences sector and improving treatment options for high-risk patients where current surgical solutions fall short.

Sectors

  • MedTech
  • Venture Capital
  • Biomedical Research

Geography

  • Italy – All the primary participants, including Approxima Srl, Panakès Partners, and ENEA Tech, are based in Italy, highlighting the country's role in fostering MedTech innovation.

Industry

  • MedTech – Approxima Srl operates in the MedTech sector, focusing on innovative medical technologies for the treatment of tricuspid insufficiency.
  • Venture Capital – Panakès Partners and ENEA Tech are involved as venture capital investors in this funding round, demonstrating their role in supporting innovative startups.
  • Biomedical Research – ENEA Tech's participation indicates a focus on biomedical research, supporting technological advancement in this field.

Financials

  • €7.3 million – The total amount raised in Approxima's Series A funding round co-led by Panakès Partners and ENEA Tech.

Participants

NameRoleTypeDescription
Approxima SrlTarget CompanyCompanyA MedTech startup and spin-off of the Politecnico di Milano, focused on developing percutaneous technologies for ventricular remodeling.
Panakès PartnersVenture Capital FirmCompanyA venture capital firm investing in life sciences technologies, co-leading the Series A funding round for Approxima.
ENEA Tech and BiomedicalVenture Capital FirmCompanyA foundation under the supervision of the Ministry of Enterprises and Made in Italy and the Ministry of Health, investing in innovative startups and SMEs.
Rucellai & RaffaelliLegal AdvisorCompanyProvided legal assistance for the investment operation in Approxima's Series A funding round.
Enrico SistiPartnerPersonPartner responsible for M&A, Corporate, and Transactional at Rucellai & Raffaelli, leading the legal advisory.
Riccardo CastagnaSenior AssociatePersonSenior Associate at Rucellai & Raffaelli, part of the legal advisory team for the transaction.